3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Venous Thromboembolism
8
Thrombocythemia, Essential
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Neoplasms
2
Thrombosis
1
Thrombocytopenia
1
Testicular Neoplasms
1
Sarcoma
1
Ovarian Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Hemorrhage
1
Hematoma
1
Hematologic Diseases
1
Glioblastoma
1
Bone Neoplasms
1
Acute Coronary Syndrome
1
Interventions
Thrombopoietin
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Aspirin
×
Classical hematology
×
Clear all
NCT06866964
2026-02-02
ASPIRE
Wake Forest University Health Sciences
Phase 2
Recruiting
35 enrolled